Foley Hoag LLP represented Modern Hydrogen on the deal. Modern Hydrogen (formerly Modern Electron), a sustainable heat and hydrogen company, announced an oversubscribed $32.8 million Series...
You must be a Standard 1 Year member to access this content.
Foley Hoag represented Ginkgo Bioworks on the deal. Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading platform for cell programming and biosecurity, announced its acquisition of StrideBio’s adeno-associated...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Purdue Research Foundation on the deal. Purdue Research Foundation, a private not-for-profit institute to advance the research of Purdue University, announced the...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Genialis on the deal. Genialis, a computational precision medicine company, announced its $13M Series A financing led by Debiopharm Innovatoin Fund and Taiwania...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Daewoong Pharmaceutical on the deal. South Korea’s Daewoong Pharmaceutical (“Daewoong”) secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based multinational company focused...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Lantheus Holdings on the deal. Lantheus Holdings (Nasdaq: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions,...
You must be a Standard 1 Year member to access this content.
Holland & Hart represented Holcim on the deal. Holcim, a global leader in innovative and sustainable building solutions, announced the acquisition of the sand and aggregates quarries...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Alcyone Therapeutics on the deal. Alcyone Therapeutics (Alcyone) announced the negotiation of a license and collaboration agreement with Biogen Inc. (Nasdaq: BIIB) to...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Applied Genetic Technologies Corporation (“AGTC”) on the deal. Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC”), a clinical-stage biotechnology company focused on the development...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Lantheus Holdings, Inc. on the deal. Lantheus Holdings, Inc. (NASDAQ: LNTH) announced a Rule 144A offering of $575 million aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP provided legal counsel to Gores, while Kirkland & Ellis LLP served as legal advisor to Coral Tree. Coral Tree Partners, a Los Angeles-based...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Alloy Therapeutics on the deal. Alloy Therapeutics, a biotechnology ecosystem company, announced a $42 million Series D financing round led by its existing...
You must be a Standard 1 Year member to access this content.
